Immunomic TherapeuticsImmunomic Therapeutics
Immunomic TherapeuticsImmunomic Therapeutics
  • Technology
  • Partnerships
  • Clinical Trials
  • People
  • Careers
  • Media
  • Contact Us
  • Technology
  • Partnerships
  • Clinical Trials
  • People
  • Careers
  • Media
  • Contact Us

Highlights

Highlights

  • Highlights
  • Events
  • Blog
  • News
  • Articles
  • Press Releases
  • Immunomic Therapeutics and Astellas Pharma announce exclusive licensing agreement for LAMP-Vax platform to prevent and treat allergies

    Highlights Press Releases
    -Immunomic Therapeutics to receive upfront payment of $300 million plus 10 percent royalties from potential products for allergic diseases, including peanut allergy- -Immunomic Therapeutics to retain rights of LAMP-vax platform
    Read more
123
← Previous page


Content
  • Technology
  • Partnerships
  • People
  • Media
  • Contact Us
Careers
  • Careers
  • Compensation & Benefits
  • Culture & Beliefs
Social
  • Facebook
  • Twitter
  • Google+
  • LinkedIn
  • Youtube
Telephone
+1.301.968.3501

Address
15010 Broschart Road Suite 250
Rockville, MD 20850

© 2017 Immunomic Therapeutics, Inc. All Rights Reserved.